Module 4: Therapeutics
According to the National Advisory Council on Prescription Drug Misuse, Canada has become the “world’s second-largest per-capita consumer” of prescription opioids (2013, p. 1). There is considerable controversy, however, about the efficacy of opioids and sedatives in the treatment of pain, anxiety, and insomnia in non-life-threating conditions and in chronic non-cancer conditions. In many situations, it is important to seek non-pharmacologic and non-controlled substance alternatives prior to making a decision to prescribe a CDS. This module examines when and how to prescribe CDS safely and appropriately. It also discusses how to taper CDS in the therapeutic management of patients.
Each lesson in Module 4 addresses one of the following learning outcomes:
- Make informed decisions regarding when to prescribe CDS.
- Articulate the principles of safe and appropriate prescribing of CDS.
- Write a prescription that contains the necessary elements for safety and appropriateness.
- Articulate approaches to trials, tapering, and rotation of CDS in therapeutic management of pain, anxiety, insomnia, and ADHD.
National Advisory Council on Prescription Drug Misuse. (2013). First Do No Harm: Responding to Canada’s Prescription Drug Crisis.